Jeffrey Bluestone

Dr. Jeffrey A. Bluestone is a Managing Director at Vie Ventures, Inc., an Independent Director at Gilead Sciences, Inc., a Chief Executive Officer at Xconomy, Inc., a Member at American Academy of Arts & Sciences, a Member at National Academy of Medicine (United States), a Member at National Academy of Sciences and a Professor at The University of California, San Francisco.
He is on the Board of Directors at Gilead Sciences, Inc., Sonoma Biotherapeutics, Inc. and The Parker Institute For Cancer Immunotherapy.
Dr. Bluestone was previously employed as an Independent Director by Provention Bio, Inc., a Co-Founder by Celsius Therapeutics, Inc., and a Director & Professor by The Ben May Department For Cancer Research.
He also served on the board at Immune Tolerance Network and IMMUNOMETABOLISM NEWCO INC.
He received his graduate degree from Rutgers State University of New Jersey and a doctorate degree from Weill Cornell Graduate School of Medical Sciences.